Bruker (FRA:BKD) Cyclically Adjusted FCF per Share: €1.05 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BKD Bruker Corp FRA:BKD
86 GF Score
Price €51.50
GF Value €55.57
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Cyclically Adjusted FCF per Share?

Bruker FRA:BKD +1.36% 86 Cyclically Adjusted FCF per Share is €1.05 as of Mar. 2026. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €55.57 (Fairly Valued). The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bruker's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.266. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.05 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bruker's average Cyclically Adjusted FCF Growth Rate was -5.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bruker was 93.10% per year. The lowest was 2.10% per year. And the median was 10.65% per year.

As of today (2026-07-20), Bruker's current stock price is €51.50. Bruker's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €1.05. Bruker's Cyclically Adjusted Price-to-FCF of today is 49.05.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bruker was 98.24. The lowest was 24.94. And the median was 53.33.


Bruker  (FRA:BKD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bruker's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=51.50/1.05
=49.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bruker was 98.24. The lowest was 24.94. And the median was 53.33.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bruker Cyclically Adjusted FCF per Share Related Terms


Bruker Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bruker's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Cyclically Adjusted FCF per Share Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 1.03 1.10 1.21 1.01

Bruker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.05 0.95 1.01 1.05

FRA:BKD vs GKOS, BIO, PODD: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Bruker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted Price-to-FCF falls into.


FRA:BKD
86GF Score
Bruker Corp FRA:BKD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bruker's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.266/330.2130*330.2130
=0.266

Current CPI (Mar. 2026) = 330.2130.

Bruker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.049 241.018 0.067
201609 0.150 241.428 0.205
201612 0.470 241.432 0.643
201703 0.123 243.801 0.167
201706 -0.149 244.955 -0.201
201709 0.133 246.819 0.178
201712 0.492 246.524 0.659
201803 0.182 249.554 0.241
201806 0.148 251.989 0.194
201809 0.088 252.439 0.115
201812 0.626 251.233 0.823
201903 0.020 254.202 0.026
201906 -0.042 256.143 -0.054
201909 0.211 256.759 0.271
201912 0.625 256.974 0.803
202003 0.026 258.115 0.033
202006 -0.049 257.797 -0.063
202009 0.357 260.280 0.453
202012 0.930 260.474 1.179
202103 0.402 264.877 0.501
202106 -0.004 271.696 -0.005
202109 0.042 274.310 0.051
202112 0.639 278.802 0.757
202203 0.353 287.504 0.405
202206 -0.393 296.311 -0.438
202209 0.080 296.808 0.089
202212 0.874 296.797 0.972
202303 0.395 301.836 0.432
202306 -0.066 305.109 -0.071
202309 0.109 307.789 0.117
202312 1.091 306.746 1.174
202403 0.003 312.332 0.003
202406 -0.148 314.175 -0.156
202409 0.034 315.301 0.036
202412 0.964 315.605 1.009
202503 0.237 319.799 0.245
202506 -0.850 322.561 -0.870
202509 -0.304 324.800 -0.309
202512 0.998 324.054 1.017
202603 0.266 330.213 0.266

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €1.05 mean?
Bruker (FRA:BKD) has a Cyclically Adjusted FCF per Share of €1.05 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bruker and its competitors.
Is Bruker's Cyclically Adjusted FCF per Share too high?
Bruker's current Cyclically Adjusted FCF per Share is €1.05. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Cyclically Adjusted FCF per Share compare to GKOS and BIO?
Bruker's Cyclically Adjusted FCF per Share of €1.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bruker and its competitors. Bruker's current Cyclically Adjusted FCF per Share is €1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €55.57, compared to a current price of €51.50 — trading 7.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €1.05. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Cyclically Adjusted FCF per Share is €1.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €51.50 is trading 7.3% below its estimated GF Value™ of €55.57. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Cyclically Adjusted FCF per Share: €1.05
  • GF Value™: €55.57 vs. price of €51.50 (7.3% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for FRA:BKD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price
€55.57
GF Value